Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
5/2/2013 8:13:39 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Actos Diabetes Drug Tied to Cancer, Jury is Told
4/16/2013 7:34:41 AM
More...
|
The New England Journal of Medicine Publishes Pivotal Trial Data for Affymax, Inc. (AFFY), and Takeda Pharmaceuticals's OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis
1/24/2013 9:01:03 AM
More...
|
Takeda Pharmaceuticals Release: American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
9/6/2012 12:14:48 PM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Opens China Clinical Trial Center in Shanghai
8/10/2012 11:17:51 AM
More...
|
Takeda Pharmaceuticals and Affymax, Inc. (AFFY) Announce Supply Agreement for OMONTYS®(peginesatide) Injection With Renal Care Group, Inc. (RCGI)
8/9/2012 10:22:46 AM
More...
|
Takeda San Diego's Vice President to Present at Upcoming Symposium
10/15/2009 1:55:27 PM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Acquires The Rights To DPP4 Inhibitors Granted To PPD, Inc. (PPDI); Upfront Payment Of $15.0 Million
10/19/2005 5:09:34 PM
More...
|